Background: The 30-day readmission rate for patients with a left ventricular assist device implantation at a large, urban, Midwest hospital system (from October 2013 to September 2014) was estimated at 32.1%. Problem Statement: Readmission rates were a concern at this facility. Review of the readmissions, change in practice, and home expectations of patients and families have identified an opportunity to improve the transitions of care for this left ventricular assist device (LVAD) program. Therefore, the purpose of this project was to evaluate the effectiveness and feasibility of a transitional care model (TCM) for care of patients with left ventricular devices. Methods: Ten patients were enrolled in the pilot that was implemented in June 2015. A transitional care nurse trained to support patients with ventricular assist devices was used to facilitate patient flow. The goal was to create an individualized plan for the development or improvement of self-management skills to decrease readmission rates. The transitional care nurse collaborated with the ventricular device team. Outcomes: The 30-day readmission rate during the pilot was 14.3% compared to the previous annual overall rate of 42.6%. Implications for Practice: Based on these results, further research is recommended into interventions consistent with the TCM to advance care coordination and to facilitate care transition in the this fragile patient population.
Introduction
Patients who have heart failure may continue to deteriorate even with guideline-directed medical therapy. 1 The gold standard for advanced heart failure is heart transplantation; however, there is a shortage of available organs. The left ventricular assist device (LVAD) is a mechanical circulatory assist device that supports ventricular function and is a viable option in lieu of transplantation for some patients 2 to extend and improve the quality of life. Heart failure programs must also be cognizant of the Centers for Medicare and Medicaid Services initiative to minimize 30-day readmission for patients with heart failure.
Local Problem
At a large, urban, Midwest healthcare system, the LVAD program grew from performing 6 implantations in 2009 to 40 in 2015. The number of patients with an LVAD in this health-care system increased to 76 in 2015, with estimated readmission rates at 32.1%, using the QualityNet readmission measures. 3 Although no national benchmarks are available, a decreased readmission rate was deemed to be warranted. With heart failure readmissions at 25% in this health system, a similar or decreased rate was sought for the LVAD program as well. The root cause of the readmissions for this LVAD program was identified as gastrointestinal bleeding, heart failure exacerbation, or infection.
Standard of Care
At the start of this program, the LVAD coordinators completed the home inspections as part of the patient evaluation process. This inspection, which occurs after a preliminary decision by the potential candidate and care team for insertion of an LVAD, included completion of an environmental and individual assessment checklist. Due to increased demands on current staffing, this practice was not sustainable and the home assessment checklist was given to the potential candidate to complete. Once the assessment of the environment was completed and the individual determined to be appropriate, the LVAD insertion would take place. Standard of discharge care included patient and family education before and throughout the hospital stay, which included, but was not limited to, sterile driveline dressing changes, LVAD maintenance, emergency procedures, medications, and heart failure signs and symptoms. A scheduled follow-up visit for new patients for the following day, after hospital discharge, weekly clinic appointments that tapered to monthly, and home health nurse visits trained on LVAD emergency protocol such as no chest compressions and changing controllers. It is also important to note the home health nurses did not complete the routine LVAD care that was sole responsibility of the patient and his or her family. With the deterioration of home inspections and home care limited to lay persons, care transitions became a rising concern.
Statement of the Problem
Hospital readmission rates for the LVAD patient population is a concern among device programs, with bleeding, cardiacrelated causes, infection, and thrombosis as the leading causes. [4] [5] In reviewing the indications for readmissions, changes in home inspection practice by the LVAD program, and home health nurse LVAD care expectations, an opportunity to improve transitions of care was identified. Therefore, the purpose of this project was to evaluate the effectiveness and feasibility of a transitional care model (TCM) pilot program in an LVAD program.
The TCM
Comprehensive transitional care interventions have been shown to decrease readmissions and health-care costs for hospitals. 6 However, transitional care is distinct from and a complementary addition to case management, disease management, care coordination, discharge planning, and primary care. 7 Using the TCM to guide care may be able to decrease readmission rates, which is important to the health system.
The TCM is a comprehensive, holistic approach to care that involves collaboration between patient and caregiver in both hospital planning and home follow-up care. The model places the patient and caregiver at the center of care. 8 The TCM's 10 components (see Table 1 ) are facilitated by a transitional care nurse. 9 The transitional care nurse's efforts in educating and promoting self-management in managing symptoms, coordination of care, and maintaining relationships may prove to be beneficial to those living with an LVAD.
Methods Design
The implementation of the small pilot project took place in the LVAD program. A convenience sample of eligible participants included newly implanted or readmitted LVAD patients living within a 50-mile radius of the hospital. Eligible participants were identified and approached to participate if they were scheduled for LVAD surgery, transferred out of the intensive care unit (ICU), or rehospitalized. Participants were English-speaking with no documented history of delirium or dementia. The University's institutional review board deemed the pilot program a quality improvement initiative (not a research initiative). Participants who met the criteria were sequentially approached to participate, and permission was obtained for the transitional care nurse to visit in the home.
Participant enrollment began in June 2015, enrolling 10 patients. A clinical nurse specialist's time was partially reallocated toward the transitional care nurse's role for this project. This LVAD-trained transitional care nurse conducted an initial home visit within 24 hours after discharge and used the LVAD TCM Patient Flow Chart adapted from the TCM 10 ( Figure 1 ). The goal for this first visit was to assess the environment and further to create an individualized plan for development or improvement of self-management skills, facilitated by the transitional care nurse (see Figure 1 for additional details). The plan was developed around the patient's identified area of health improvement, discussing their personal strengths, weaknesses, and available resources. Depending on participant preference and need, home visits or telephone follow-ups occurred weekly for up to 8 weeks. The program concluded when participants completed 8 weeks in the program or when the participant and the transition coordinator agreed that program services were no longer required. The self-management plan and any concerns were reported to the LVAD team.
Measures and Analysis
Demographic data, health characteristics, and readmission information (including admission diagnosis) were obtained 
from patient medical records. The 30-day hospital readmission rate was calculated by dividing the total number of inpatient hospital stays between June and September 2015 by the number of inpatient hospital stays within 30 days. 3 The pilot was determined to be successful if readmission rates were decreased by 25%.
Outcomes

Patient Characteristics
The participants were between the age of 32 and 68 and had either the HeartMate II or the HeartWare LVAD. Of the 10 participants, 4 were recruited at the time of readmission and 6 were newly implanted with an LVAD. Complete demographic information is given in Table 2 .
Readmission Rates
One of the 6 participants who completed the program had a preventable readmission within 30 days. The readmission rate for the 6 participants who completed the pilot program was 14.3%, which was lower than the health-care system's 2014 readmission rate of 32.1%. The 30-day hospital readmission rate for the 4 participants who failed to complete the program was 44%. The 30-day readmission rate at the end of the calendar year in 2015 and 2016 was 42.6% and 23.7%, respectively ( Figure 2 ).
Discussion
First Home Visit
For the transition coordinator nurse pilot program, the first home visit was to be conducted at the patient's home the day after hospital discharge. The health-care system's outpatient management policy mandates that patients with a newly implanted LVAD have a clinic appointment the day after hospital discharge, for patients with LVAD who were readmitted, a clinic appointment was made within a week of hospital discharge. For the majority of project participants, the first home visit, and clinic appointment for patients with newly implanted with an LVAD was scheduled within the pilot program's protocol (N ¼ 8) both on the day following discharge. However, for patients living in the outskirts of the 50-mile radius, scheduling this visit proved more challenging (N ¼ 2). For these patients, the first transitional care nurse visit took place at their first clinic appointment. For future studies, flexibility in scheduling the first home visit is necessary when implementing the transitional care program.
Potential participant is identified with the VAD team and TCN.
Within 24 hours of discharge from the ICU, or patients readmitted, participants will be evaluated based on the inclusion criteria.
Participants who have agreed and consented to the TCM pilot will be enrolled.
TCN visits the participant daily during the hospitalization.
TCN visits the participant within 24 hours after transition from hospital to home.
TCN implements care plan and, with each patient encounter, reassesses patient's status and the plan with the patient, family caregiver, and VAD team.
Length of intervention will be two months post-hospitalization.
TCN conducts comprehensive assessment of the goals and needs of patient and caregiver, and initiates collaboration with the VAD team.
TCN collaborates with members of the VAD team to design and coordinate evidence-based transitional care plan.
The VAD team is available 24 hours a day. TCN will contact the participant at least weekly (home visits during the first month and weekly telephone outreach throughout the intervention).
An evidenced-based assessment and TCN clinical judgement will inform recommendations for patient-centered follow-up care. 
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Although not measured directly in this study, it is important to include the potential impact of this study protocol on relationships between care providers and patients. Maintaining the relationships between the patient and LVAD team during the program was unanticipated and likely a contributor to success in decreased readmission rates. The transitional care nurse facilitated the LVAD patient's goal of successful selfmanagement and, once the patient completed the program, the LVAD clinical nurse coordinator continued to be the patient's primary connection to the hospital. In implementing transitional care in a specialized patient population (LVAD patients), it is critical that the relationship between the patient and the LVAD team be maintained and continued without interruption; because the transitional care program is time limited, the patients will continue to be cared for by the LVAD team.
Limitations
One limitation of this pilot program was the small number of participants. A total of 82 patients were implanted with an LVAD during the year of the pilot. Six completed the 8-week program, 3 patients changed their minds about participation at the initial home visit, and 1 was discharged from the pilot because he was unable to participate in self-management activities. One patient did not meet criteria to participate during the pilot. Due to the nature of this small pilot, a true representation of the larger LVAD population was not assessed. Therefore, it is recommended that the transitional care programs be piloted or implemented with a larger sample to determine whether the decreased readmission rate is generalizable.
Travel distance for the transitional care nurse may be a concern. A 50-mile radius allowed for a maximum of 1 hour of travel time to the participant's home, a 1-hour home visit, and a 1-hour drive back to the hospital. For health system administrators contemplating implementing a transitional care program, assessment of the catchment area and travel distances is imperative.
Implications
This pilot program guided by the principals of the transition care model appears to have reduced LVAD patient readmission rates. The goal of decreasing hospital readmissions in 30 days was achieved, down to 14.3% from 32.1%. Patients with LVADs are unique because they have a chronic heart disease and have had a surgical intervention to alleviate heart failure symptoms. Successful outcomes were achieved in this small, pilot program, filling a gap in the literature pertaining to transitional care implementation in an LVAD population. Based on these results, further research identifying interventions consistent with the TCM to advance care and to facilitate transitions in the LVAD patient population.
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